ArticleJournal of experimental & clinical cancer research : CR2025

Chronic administration of metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3β-MCL-1 pathway by inhibiting the tmCLIC1 membrane protein in glioblastoma-initiating cells.

Francesca Cianci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.